 鲜花( 85)  鸡蛋( 2)
|

楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval. A# C0 s5 L/ T4 }1 d2 Y
3 J8 [5 ~- E0 V4 ]6 w3 A/ GEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.( A5 q/ m8 p: H% T* O4 M6 L
, G! s) `1 @$ ^1 R' @0 s
BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
0 h# Y, p1 P3 a' p
) ~/ e) C2 [/ @4 I h* B; `& e7 \2 A! r! }' U* r- f# f
EDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.4 Q2 Y' d' u! ]) E3 z9 b
: Q, S1 K) k- f& ~' Z) e* x
The agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
2 } s1 Z. X( R- m/ T% N. O
# ~: s6 ~4 ^. }$ x0 PThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
5 i3 h6 W" n9 d
3 A) Q& \7 W3 J4 c7 s) y$ PIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
0 y. s3 n' n2 h, h$ H
% V2 O( \' ]/ g/ P, R0 k, \It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
) T4 H# v$ }6 `, o% C, X& }4 Z9 z0 o: M6 G, F7 w
"As a scientist, it's one of the highlights of my CAREER," Shan said.9 M5 L6 r+ w0 K
# d$ D* S: T5 `1 k
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
3 H! X. I8 b9 j. p2 W
, A. O' ~% |6 R% h6 P( l. aIt's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.. M+ \5 h C/ F% E' {2 M9 S# `
( h7 \7 [0 w' R0 B7 P
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.; b+ ~2 `0 N7 q. s
e1 Q' [2 J/ L. r2 k( y; F4 I
The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.3 b4 ?& {- p" w0 }, S$ N
5 y5 }( N" Y6 \& T
, [: G( z0 v) x$ U+ F
http://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|